HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation.

AuthorsTomohiro Aoki, Yasuhiko Harada, Erina Matsubara, Takanobu Morishita, Tatsuya Suzuki, Masanobu Kasai, Toshiki Uchida, Toyonori Tsuzuki, Shigeo Nakamura, Michinori Ogura
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 31 Issue 22 Pg. e390-3 (Aug 01 2013) ISSN: 1527-7755 [Electronic] United States
PMID23796993 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Cytarabine
  • Rituximab
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cytarabine (administration & dosage)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, pathology)
  • Lymphomatoid Granulomatosis (drug therapy, pathology)
  • Recurrence
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: